FAP ponatinib (Tract Bio)

N/A

Report date: 2025/03/31 14:59:08
NME

Base Information

Drug NameFAP ponatinib (Tract Bio)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibroblast activation protein alpha modulators
TargetsProlyl endopeptidase FAP
Therapy Area/IndicationsSolid tumoursLeukemia, Myelogenous, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTract Bio
China Registration ClassN/A

Develop Information

Active CompaniesTract Bio
Inactive CompaniesN/A
Active IndicationsSolid tumoursLeukemia, Myelogenous, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A